申请人:CYCLACEL LTD
公开号:WO2004043953A1
公开(公告)日:2004-05-27
The present invention relates to substituted pyrimidines of formula (I), their preparation, pharmaceutical compositions containing them and their use as inhibitors of cyclin-dependent kinases (CDKs) and hence their use in the treatment of proliferative disorders and/or viral disorders.
本发明涉及式(I)的取代嘧啶化合物,它们的制备,含有它们的药物组合物,以及它们作为细胞周期依赖性激酶(CDKs)抑制剂的用途,因此可用于治疗增殖性疾病和/或病毒性疾病。